The use of multifunctional nanoparticles (NPs), usually in the range of 3–100 nm, with their newly discovered properties – such as superparamagnetic (SPM) behaviour, enhancement of activity and selectivity in catalytic processes and localised surface plasmon resonance (LSPR) – offers new technical possibilities for biomedical applications such as magnetic hyperthermia (MH), plasmonic photothermal therapy (PPTT) and enhanced magnetic resonance imaging (MRI). In addition, the small size of NPs presents a unique opportunity to interfere, in a highly localised and specific way, with natural processes involving viruses, bacteria or cells and allows interference in the development of complex diseases like many types of cancer and neuropathies (Alzheimer's, Parkinson's, Kreutzer–Jacobs'). The design of biological applications based on MH is a chemical challenge and core@shell structures are most often used to endow NPs with multifunctional abilities. The success of such MH‐based biological applications depends on the magnetic functionality of the core as well as the properties of the surface shell in direct interaction with the biological medium. In this review we will describe the most important methodologies developed to synthesise magnetic core@shell nanostructures and their MH applications.

In this paper, novel magnetic silica nanocomposites were prepared by anchoring magnetite nanoparticles onto the outer surface of mesoporous SBA-15 silica; the magnetic nanoparticles were prepared by microemulsion and solvothermal methods, varying the synthesis conditions in order to control the final physicochemical, textural and magnetic properties. The morphology and mesostructure of the materials were characterized by X-ray diffraction (XRD), Fourier-Transform Infrared Spectroscopy (FTIR), N 2 adsorption-desorption, and Transmission and Scanning Electron Microscopy (TEM and SEM). Magnetic silica nanocomposites feature a two-dimensional hexagonal arrangement constituted by a homogeneous pore channel system with diameters between 13 and 18 nm and a Brunauer-Emmett-Teller (BET) surface area higher than 260 m 2 g À1 . The different morphologies of the samples are given by the presence of diverse magnetic nanoparticle arrangements covalently linked onto the outer surface of the mesoporous silica rods. This confers on them a superparamagnetic behaviour with a magnetic response between 50-80 emu g À1 , even though the weight percent of magnetite present in the samples does not exceed 21.7%. In addition, the magnetic nanocomposites exhibit magnetic hyperthermia with moderate Specific Absorption Rate (SAR) values.

No abstract

Neurological diseases of diverse aetiologies have significant effects on the quality of life of patients. The limited self-repairing capacity of the brain is considered to be the origin of the irreversible and progressive nature of many neurological diseases. Therefore, neuroprotection is an important goal shared by many clinical neurologists and neuroscientists. In this review, we discuss the main obstacles that have prevented the implementation of experimental neuroprotective strategies in humans and propose alternative avenues for the use of neuroprotection as a feasible therapeutic approach. Special attention is devoted to nanotechnology, which is a new approach for developing highly specific and localized biomedical solutions for the study of the multiple mechanisms involved in stroke. Nanotechnology is contributing to personalized neuroprotection by allowing us to identify mechanisms, determine optimal therapeutic windows, and protect patients from brain damage. In summary, multiple aspects of these new players in biomedicine should be considered in future in vivo and in vitro studies with the aim of improving their applicability to clinical studies.